HCPCS Level IIdrugActive
J3241
Inj. teprotumumab-trbw 10 mg
BETOS: O1E
Effective: 2020-10-01
Referenced in 1 policies
Description
Injection, teprotumumab-trbw, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tepezza
Manufacturer
Amgen Inc
HCPCS Dosage
10 MG
Billing Units
50.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.